Anthera Pharmaceuticals - Daily Chart

Name
*Data as of: 2017-10-31
Company Summary Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases. The Company's clinical-stage programs include one Phase 3 ready program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. A-623 targets elevated levels of B-lymphocyte stimulator, or BLyS (also known as BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sj?gren's Syndrome, Graves' Disease and others. Anthera Pharmaceuticals, Inc. is headquartered in Hayward, California.
Daily Stock Data   Dates and Ratios   Company Background
Symbol ANTH Earnings Date 2017-11-06 Exchange NASDAQ
Name Anthera Pharmaceuticals Ex Dividend Date N/A Sector Medical
Close $1.62 Exp. Dividend Amount N/A Industry Medical - Biomed / Biotech
$ Change
+0.02
Dividend Yield 0.00 Market Cap 18M
% Change
+1.30%
Alpha -0.90 Enterprise Value 6M
Open 1.60 Beta 4.65 Shares 1000s 10,906
Days Range 1.53 - 1.62 Daily ATR 0.14 Incorp Date 2004
52 Week Range 1.20 - 22.48 Daily ATR% 8.57% IPO Date 2010-03-01
Volume 206,900 Price/Earnings 0.00 Location Hayward,CA
Avg Vol 50d 438,755 Price/Book 1.42 ADR No
Vol % Chg vs 50 Day
-52.80%
Price/Sales 0.00 Options Yes
Up/Down Volume 1.20 PEG 0.00 ETF/Closed End Fund No
AD Rating Timeliness Rating Industry Group Rank
Symbol Comp Rating EPS Rating SMR Rating RS Rating Sponsor Rating Current Last Week Current Last Week Ind Group RS Current Last Week 3 Months Ago 6 Months Ago Industry Group Sector
ANTH 30 57 E 6 B B B D D A+ 2 3 5 19 Medical-Biomed/Biotech MEDICAL
   
Stock Symbol   Sector   Industry Group
ANTH   Medical   Medical - Biomed / Biotech
Overall Stock Ratings   Stock Ratings within Sector   Stock Ratings within Industry
Full 37.21 Full 37.8647 Full 35.41
Earnings 54.91 Earnings 76.62 Earnings 88.20
Sales 19.60 Sales 15.76 Sales 13.59
Margins 8.29 Margins 18.55 Margins 20.71
Valuation 68.82 Valuation 55.53 Valuation 46.10
Best Rated Stocks Overall   Best Rated Stocks in Sector:
Medical
  Best Rated Stocks in Industry:
Medical - Biomed / Biotech
JP 100.00 ABMD 100.00 CORT 100.00
ESNT 99.98 CORT 99.87 SUPN 99.78
LRCX 99.96 ALGN 99.75 LGND 99.55
YY 99.94 FONR 99.62 VRTX 99.33
FB 99.92 HSKA 99.49 BIVV 99.11
*All ratings range from 0 to 100 with 100 being the highest.
 
Stock Symbol   Sector   Industry Group
ANTH   Medical   Medical - Biomed / Biotech
% Gain   Average Stock Gain % in Sector   Average Stock Gain % in Industry
1 Day
+1.30%
1 Day
+0.09%
1 Day
-0.61%
1 Week
+9.46%
1 Week
-1.48%
1 Week
-2.21%
2 Weeks
+5.19%
2 Weeks
-1.64%
2 Weeks
-5.33%
3 Weeks
-9.50%
3 Weeks
-1.01%
3 Weeks
-6.13%
1 Month
+13.29%
1 Month
-1.01%
1 Month
-5.29%
3 Months
+31.71%
3 Months
+5.23%
3 Months
+7.11%
6 Months
-34.68%
6 Months
+11.74%
6 Months
+19.45%
1 year
-91.20%
1 year
+28.80%
1 year
+42.57%
YTD
-68.85%
YTD
+27.09%
YTD
+42.32%
 
Sector Info   Sector Ranking   Average Stock Gain % in Sector
Symbol ANTH Current 20 1 Day
+0.09%
Sector Medical Yesterday 21 1 Week
-1.48%
Market Val(Bil) 4,283.83B 1 Week Ago 12 2 Weeks
-1.64%
Industry Groups 399 2 Week Ago 19 3 Week
-1.01%
Total Stocks 704 3 Week Ago 17 1 Month
-1.01%
New Highs 24 1 Month Ago 19 3 Month
+5.23%
New Highs % 3.41% 3 Month Ago 9 6 Months
+11.74%
New Lows 27 6 Month Ago 29 1 year
+28.80%
New Lows % 3.84% 1 Year Ago 31 YTD
+27.09%
 
Industry Group Info   Industry Group Ranking   Average Stock Gain % in Industry
Symbol ANTH Current 50 1 Day
-0.61%
Industry Group Medical - Biomed / Biotech Yesterday 67 1 Week
-2.21%
Market Val(Bil) 735.54B 1 Week Ago 42 2 Weeks
-5.33%
Total Stocks 399 2 Weeks Ago 22 3 Weeks
-6.13%
New Highs 9 3 Weeks Ago 22 1 Month
-5.29%
New Highs % 2.26% 1 Month Ago 25 3 Months
+7.11%
New Lows 15 3 Months Ago 16 6 Months
+19.45%
New Lows % 3.76% 6 Months Ago 104 1 Year
+42.57%
      1 Year Ago 154 YTD
+42.32%
Data as of: 2017-10-31
Daily Stock Data   Dates and Ratios   Company Background
Symbol ANTH Earnings Date 2017-11-06 Exchange NASDAQ
Name Anthera Pharmaceuticals Ex Dividend Date N/A Sector MEDICAL
Close 1.62 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 0.02 Dividend Yield 0 Market_Cap_mil 17.7
% Change 1.3 Alpha -0.9 Enterprise_Val_mil 6.3
Open 1.6 Beta 4.65 Shares_1000s 10906
Day's Range 1.53 - 1.62 Daily ATR 0.14 Incorp_Date 2004
52 Week Range 1.2 - 22.48 Daily ATR% 8.57 IPO Date 2010-03-01
Volume 20,690,000 Price/Earnings Location Hayward,CA
Avg Vol 50d 43,875,500 Price/Book 1.42 ADR No
Short Volume 1,373,513 Price/Sales Options Yes
Shrt Int Pcnt Chg -28.3 PEG ETF/Closed End Fund No
Data as of: 2017-10-31
Daily Stock Data   Dates and Ratios   Company Background
Symbol ANTH Earnings Date 2017-11-06 Exchange NASDAQ
Name Anthera Pharmaceuticals Ex Dividend Date N/A Sector MEDICAL
Close 1.62 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 0.02 Dividend Yield 0 Market_Cap_mil 17.7
% Change 1.3 Alpha -0.9 Enterprise_Val_mil 6.3
Open 1.6 Beta 4.65 Shares_1000s 10906
Day's Range 1.53 - 1.62 Daily ATR 0.14 Incorp_Date 2004
52 Week Range 1.2 - 22.48 Daily ATR% 8.57 IPO Date 2010-03-01
Volume 20,690,000 Price/Earnings Location Hayward,CA
Avg Vol 50d 43,875,500 Price/Book 1.42 ADR No
Short Volume 1,373,513 Price/Sales Options Yes
Shrt Int Pcnt Chg -28.3 PEG ETF/Closed End Fund No
Sales Ratings (0 to 10) Sales Accelerating % Sales Growth % Sales Growth Rank
Symbol Overall within Sector within Industry Annual Sales 2Q 3Q Last Qtr Last Yr 3 Years 5 Years Last Qtr Last Yr 3 Years 5 Years
ANTH 19.6 15.76 13.59 0.1M No No -95
Data as of: 2017-10-31
Daily Stock Data   Dates and Ratios   Company Background
Symbol ANTH Earnings Date 2017-11-06 Exchange NASDAQ
Name Anthera Pharmaceuticals Ex Dividend Date N/A Sector MEDICAL
Close 1.62 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 0.02 Dividend Yield 0 Market_Cap_mil 17.7
% Change 1.3 Alpha -0.9 Enterprise_Val_mil 6.3
Open 1.6 Beta 4.65 Shares_1000s 10906
Day's Range 1.53 - 1.62 Daily ATR 0.14 Incorp_Date 2004
52 Week Range 1.2 - 22.48 Daily ATR% 8.57 IPO Date 2010-03-01
Volume 20,690,000 Price/Earnings Location Hayward,CA
Avg Vol 50d 43,875,500 Price/Book 1.42 ADR No
Short Volume 1,373,513 Price/Sales Options Yes
Shrt Int Pcnt Chg -28.3 PEG ETF/Closed End Fund No
Margins Ratings (0 to 10) Average After Tax Margins
Symbol Overall within Sector within Industry Pretax Margin Last Qtr After Tax Margin Accel 3Q After Tax Margin Last Qtr 2 Qtr 3 Qtr 4 Qtr 5 Qtr 6 Qtr
ANTH 8.29 18.55 20.71 -38291.7 No
 
Stock Symbol   Sector   Industry Group
ANTH   Medical   Medical - Biomed / Biotech
Ratios   Average Ratios in Sector   Average Ratios in Industry
Price/Earnings (PE) 0.00 Price/Earnings (PE) 70.87 Price/Earnings (PE) 220.10
Price/Book (PB) 1.42 Price/Book (PB) 3.20 Price/Book (PB) 5.66
Price/Sales (PS) 0.00 Price/Sales (PS) 212.79 Price/Sales (PS) 412.66
Price/Cash Flow (PCF) -0.36 Price/Cash Flow (PCF) -2.57 Price/Cash Flow (PCF) -10.95
PEG 0.00 PEG 2.63 PEG 0.70
Dividend Adj PEG 0.00 Dividend Adj PEG 2.31 Dividend Adj PEG 0.69
Return on Equity (ROE) -213.00 Return on Equity (ROE) -91.54 Return on Equity (ROE) -130.23
Yield 0.00 Yield 1.25 Yield 1.74
Current Ratio 3.28 Current Ratio 5.75 Current Ratio 7.27
Debt % 0.00% Debt % 88.26% Debt % 45.95%
Long Term Debt/Work Capital 0.00 Long Term Debt/Work Capital 1.20 Long Term Debt/Work Capital 0.22
 
Stock ANTH   Exponential Moving Averages   Simple Moving Averages
Name Anthera Pharmaceuticals EMA 10 days
1.63(-0.61%)
SMA 10 days
1.62(0%)
Close $1.62 EMA 20 days
1.61(0.62%)
SMA 20 days
1.66(-2.41%)
$ Change
+0.02
EMA 50 days
1.57(3.18%)
SMA 50 days
1.51(7.28%)
% Change
+1.30%
EMA 89 days
1.81(-10.5%)
SMA 79 days
1.48(9.46%)
Volume 206,900 EMA 100 days
1.96(-17.35%)
SMA 100 days
1.52(6.58%)
Avg Volume 438,755 EMA 200 days
4.64(-65.09%)
SMA 200 days
2.53(-35.97%)
Vol% vs. Avg Vol
-52.80%
           
Up/Down Vol 1.20   Keltner Channel   Bollinger Band
Distribution Days 3   Upper
1.80(-10%)
  Upper
1.85(-12.43%)
ATR 0.14   Mid
1.62(0%)
  Mid
1.66(-2.41%)
ATR% 8.57%   Lower
1.44(12.5%)
  Lower
1.47(10.2%)